STRO · Sutro Biopharma, Inc. · Proposed Sales
$9.20
-0.74 (-7.44%)
At close · Nov 5
Return incl. dividend (before tax)
Market Cap
$153.71M
Shares
16.58M
Volume · Nov 5
771.86K
Avg daily vol (3M)
319.6K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-20 | BARBARA LEYMAN | Former Officer | 8,929 | 2026-01-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-29 | NICKI J VASQUEZ | Officer | 12,185 | 2024-01-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-25 | Shtylla Brunilda | Officer | 27,041 | 2023-08-25 | ETRADE FINANCIAL CORPORATION |
Showing 1–3 of 3 filings
Key facts
CIK
1382101
CUSIP
869367201
13F (30d)
31 filings
19 filers
Visit website
Investor relations